Frontlight ResearchEarly access
Trial site
Cancer Center of Guangzhou Medical University
- 6running trials
- 9closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Lung cancer8 trials
- Colorectal cancer2 trials
- Liver and biliary tract cancer2 trials
- Childhood cancers1 trial
- Chronic lymphocytic leukaemia1 trial
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- Kidney cancer1 trial
- Mantle cell lymphoma1 trial
- Melanoma1 trial
- Neuroendocrine tumours1 trial
- Ovarian cancer1 trial
- and 3 more
- Phase
- Phase 39 trials
- Phase 25 trials
- Status
- Completed8 trials
- Active, not recruiting4 trials
- Recruiting2 trials
- Terminated1 trial
- Lead sponsor
- BeiGene5 trials
- Hoffmann-La Roche4 trials
- Loxo Oncology, Inc.2 trials
- Xynomic Pharmaceuticals, Inc.2 trials
- Pierre Fabre Medicament1 trial
- and 1 more
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
Closed trials
Completed
Completed
Terminated
Completed
Completed
A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026